Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Listened to the presentation...like what I heard. AMBS is one of the worst stocks I've tried to play, but will be one of the best companies I've invested in. No doubts.
Presentation slides are posted..
http://wsw.com/webcast/marcum/ambs/
So regarding alpha syn, doesn't taking the CED approach address this and the short-comings of Cenegene, ect?
100% agree thoughts....unless they have been waiting to see if they were awarded a piece of the $10M TPP grant and multi-year partnering from MJFF to be awarded any day now(in May 2013 per MJFF site).
This would provide the same benefit with no/zero/nada obligation to share in royalty or ownership.....Huge benefit to shareholders!
I'm been looking for this to come about for several months and am beginning to think it may not come to pass. But, even if there were a slight chance, Gerald would have a been a terrible CEO to strike a deal before he knew.
MJFF site just added 2 more grants for 2013 funding..that's 3 updated today.... $10M Therapeutic Process grant to be announced by end of the month.
I hope Amarantus is the recipient of a portion of this new partnering program, but if not I would expect to here more about the potential offers on the table. Management would have been crazy to strike a deal with a partner if they could get the same benefits and cash for free from MJFF.
MJFF is beginning to update 2013 funded grants on their page..2 new ones last week and 1 new one today...
https://www.michaeljfox.org/foundation/funded-grants.php
Nothing mentioned of the Therapeutic Pipeline Process yet... According to their updates, this new program's 2 stage evaluation for approval began last September and is to be announced by the end of this month. Resulting grant is allows for up to $10M and a multiple year partnering with the recipient.
Jason Napodano B.S. in Biochemistry from Virginia Tech, B.A in Chemistry, and a minor in Math. An M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University.
Managing Director & Senior Biotechnology Analyst at Zacks Investment Research, Small-Cap Research division.
I think that there may be a reason that he has the job that he has...
His opinion may differ from your, but to suggest he is unqualified to make an evaluation would be incorrect.
BTW..should I ask my dentist for his opinion too?
"Amarantus has a relationship with Renishaw through a grant application with the Michael J. Fox Foundation, so it would not surprise us to see Amarantus team up with Renishaw later this year."
From Jason's AMBS Zack's Report, 5/22/13, pg. 13
Also, from pg.12
"MANF will be delivered to the affected areas of the brain through a next-generation implanted catheter system designed to deliver drugs at the right pressure to overcome previous failed efforts with GDNF and other neurotrophic factors. In this regard, we expect that Amarantus will strike a partnership with a firm specializing in CED ("convection enhanced delivery platform") later in 2013, with the two major players being UK-based Renishaw and German-based BrainLab."
Credit due-Gatortail found this little tidbit yesterday.
That's right..everyone stand up state your name and reason for being here....c'mon. Invest or don't. Buy or sell. Glass houses my man...
This MJFF TPP Grant thing has been dragging on since last September...not AMBS's fault. It's been a 2 stage application process with lots of evaluation time. This new program provides up to $10M and multiple years of "partnering" to pursue promising developments. ......this is "free."
If there truly have been multiple discussions and offers thrown up to Gerald in exchange for percentages/royalties, he would be the worst CEO ever to jump at one until they found out IF they could have the same for "free" from MJFF.
The awarding of this MJFF program is to happen by the end of this month....less than 2 weeks. Maybe they get it.....maybe they don't.
Either way, big news is coming soon. If they are not awarded a portion from MJFF, look for the announcement shortly thereafter about a partnership deal....one that Gerald has been sitting on until hearing the MJFF verdict. IMO
"Amarantus has a relationship with Renishaw through a grant application with the Michael J. Fox Foundation, so it would not surprise us to see Amarantus team up with Renishaw later this year."
From Jason's AMBS Zack's Report, 5/22/13, pg. 13
Also, from pg.12
"MANF will be delivered to the affected areas of the brain through a next-generation implanted catheter system designed to deliver drugs at the right pressure to overcome previous failed efforts with GDNF and other neurotrophic factors. In this regard, we expect that Amarantus will strike a partnership with a firm specializing in CED ("convection enhanced delivery platform") later in 2013, with the two major players being UK-based Renishaw and German-based BrainLab."
Credit due-Gatortail found this little tidbit yesterday.
Franchising can be huge! Up front lump payments from investors and then residual royalties to grow both parent company and franchising efforts.
This could be a huge step for a company like this.
Joboggi's sticky is purely opinion not fact.. Why is it sticky'd?
Great find Gator! I need to take some time and review that report.
Shared this thought yesterday..still think it's a plausible scenario..
This MJFF TPP Grant thing has been dragging on since last September...not AMBS's fault. It's been a 2 stage application process with lots of evaluation time. This new program provides up to $10M and multiple years of "partnering" to pursue promising developments. ......this is "free."
If there truly have been multiple discussions and offers thrown up to Gerald in exchange for percentages/royalties, he would be the worst CEO ever to jump at one until they found out IF they could have the same for "free" from MJFF.
The awarding of this MJFF program is to happen by the end of this month....less than 2 weeks. Maybe they get it.....maybe they don't.
Either way, big news is coming soon. If they are not awarded a portion from MJFF, look for the announcement shortly thereafter about a partnership deal....one that Gerald has been sitting on until hearing the MJFF verdict.
Adding to my position today. When this does move, it will be in a big way. IMO
The .04's will be gone in a blink of an eye.
Other reasons I expect to here more from MJFF in the next 10 days sometime in which the Therapeutic Process Grant from last Fall's entries will be awarded.
https://www.michaeljfox.org/research/priority-area-detail.php?neurotrophic-factors
Priorities for 2013
The Foundation is focusing its efforts on:
-Understanding several key challenges to neurotrophic factor therapy, including the interaction between neurotrophic factors and alpha-synuclein
-Identifying novel neurotrophic factors that may work better than those currently being developed
-Identifying noninvasive approaches to delivering neurotrophic factors to the brain
https://www.michaeljfox.org/foundation/publication-detail.html?id=245&category=4
Regarding Ceregene:
A positive result today could not only lead to another trial or even market approval for a trophic factor-based treatment - encouraging data could also invigorate the field to innovate alternate delivery methods for trophic factors, as well as continue to seek new trophic factors that may show even better therapeutic effect.
Just sent my complaint about TD.
Jason Napodano is Managing Director & Senior Biotechnology Analyst at Zacks Investment Research, Small-Cap Research division.
B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. An M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University.
http://bionapcfa.blogspot.ca/
sorry for the re-post jemberlin, just wanted to make sure all interested knew JN's credentials and position.
Rough day on the OTC yesterday...let's see if NNAN can show some bounce today.
I agree, But it may be MANF that brings the grant money and wipes away some of the fears of additional dillution. It'll take this, AND diagnostics, to really get the pps flying. Imo
Agreed. During the conference call last Fall, MJFF stated that a single entity "could" receive the full amount...if the proposal was perfect....so, possible, but very unlikely.
This MJFF TPP Grant thing has been dragging on since last September...not AMBS's fault. It's been a 2 stage application process with lots of evaluation time. This new program provides up to $10M and multiple years of "partnering" to pursue promising developments. ......this is "free."
If there truly have been multiple discussions and offers offered up to Gerald in exchange for percentages/royalties, he would be the worst CEO ever to jump at one until they found out IF they could have the same for "free" from MJFF.
The awarding of this MJFF program is to happen by the end of this month....less than 2 weeks. Maybe they get it.....maybe they don't.
Either way, big news is coming soon. If they are not awarded a portion from MJFF, look for the announcement shortly thereafter about a partnership deal....one that Gerald has been sitting on until hearing the MJFF verdict.
There is just too much information that we are not aware of to make judgements...call it armchair CEO, Monday morning CEO, ect...
This is a terrible penny stock to trade, but I believe a fantastic investment...a sentiment shared by many still here.
This MJFF TPP Grant thing has been dragging on since last September...not AMBS's fault. It;s been a 2 stage application process with lots of evaluation time. This new program provides up to $10M and multiple years of "partnering" to pursue promising developments. ......this is "free."
If there truly have been multiple discussions and offers offered up to Gerald in exchange for percentages/royalties, he would be the worst CEO ever to jump at one until they found out IF they could have the same for "free" from MJFF.
The awarding of this MJFF program is to happen by the end of this month....less than 2 weeks. Maybe they get it.....maybe they don't.
Either way, big news is coming soon. If they are not awarded a portion from MJFF, look for the announcement shortly thereafter about a partnership deal....one that Gerald has been sitting on until hearing the MJFF verdict.
All IMO.
Its been almost 6 weeks since an update....expect some big news this week!
I like that we're climbing....just not sure why?
News+Volume out of the gate= Good things here today
Agreed! PR's will start hitting and anyone who has been sitting on the sidelines will be chasing to catch up and wishing they were in at pps we had yesterday..
Looking for a great Friday here!
Okay, i see what u mean now....but if the "financial institution" is Dominion why not just say so?
Can you clarify that General? I'm not following the Sept10Q connection to the recent statement as you are.
Come on now Coinguy, there is more to that presentation and correction made today that just what you have shown...
What was detailed in the 10Q yesterday was simply reprint of last years May issued 10K. As management has recently admitted, they have made simple mistakes due to the lack of manpower that they have available to them. The following was also included in the annual 10K from last month and finalizes the issue. They simply did a poor cut and paste job on yesterdays 10Q and then corrected it today.
"In August 2012, the Company learned that the IP now belongs to the bankruptcy estate, and the Trustee has provided notice to the Patent and Trademark Office of the change in ownership. Further the Trustee was willing to work with Amarantus with complying with Power 3’s original agreement with Amarantus, and put forth a proposal. In November 2012, the Company responded to the Trustee’s proposal and is currently waiting for a formal reply from the Trustee.
On December 19, 2012, Amarantus Bioscience, Inc. (the “Company” or “Registrant”) entered into a bill of sale () with Lowell T. Cage, the chapter 7 trustee for Power3 pursuant to which Power3 granted to the Company interest in intellectual property relating to medical patents held by the estate of Power3, . Under the terms of the bill of sale, the Company will provide to Power3 consideration of $40,000 plus the retention of the Company’s common stock owned by Power3 in return for the intellectual property.
Amarantus is continuing to review the Company’s legal options with respect to the material misrepresentations made by the officers of Power3 and the Company’s rights in the IP." AMBS April 10K
Is this a silly mistake...absolutely! Is there any deception....no.
Sell, Sell, Sell....to me.
Gotta say, IF AMBs is running out of gas, the real bag holders would be Russ Miller who just came on board from a VP of Development position and the board members like Adam Simon and Mark Benedyk who attached their reputations to AMBS as Board members.....
wow, what a bunch of uninformed losers! <-sarcasm included. They should have checked with the IHUB board first!
BTW-With all of this concern today...only 1.8M shares transacted...that's only like $85k. Doesn't appear that everyone is running for the hills to me.
up and up!
ONCI Wednesday... Time to heat the train whistle and get this money train rolling..
Retailer..if that was referring to my post. Just reminding those long term-ers still here and holding of the possibilities.
I really do think that something from MJFF is coming...I've been calling the TPP grant for over a month. This is crunch time...it's to be announced this month.
The 2nd quarter MJFF partnering program were announced middle of May last year...would expect the same this year.
If these don't occur, you won't see these statements again from me....and I've wasted a SHXX load of time on fortune telling lessons.
MJFF TPP Grant $10M awarded the in next 2 weeks, MJFF Partnering Program??, JV with BD?...something is coming. Too much effort and too many strategic moves have been made by management. Time will tell..
4'S back in sight...
4's followed by 5's!